JPMorgan says own this drug stock. It's one Jim Cramer is itching to buy again
The Club remains optimistic about Bristol Myers and shares JPMorgan's enthusiasm about Cobenfy.
Cobenfy
since
auto-detected in 3 stories
50 days ago
page 1 of 1